explore -WSS

explore

author：comprehensive 2025-10-02 18:47:56 - browse：2

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： AI for drug discovery: Experts on separating hype from reality

WSS

HHS's proposed rule does nothing to address the climate crisis

Chemotherapy before breast cancer surgery might fuel metastasis

Intarcia’s device

Crowdfunding for medical bills sidesteps core problem, author says

Sepsis can kill a child within hours. Here's how hospitals are fighting back

AltruBio raises $225 million to develop ulcerative colitis drug

entertainment

explore

knowledge

State Dept. review finds Biden bears some blame for Afghanistan failures

Class action alleges UnitedHealth concealed DOJ probe

In age of alternative facts, a scholarly course on calling out crap

Welsh Carson private equity firm escapes from FTC antitrust case

Hepatitis C has a cure — but many Americans still lack access to it

Chemotherapy before breast cancer surgery might fuel metastasis

Medical records are filled with copy

Brain technologies pose threats that are all too real, experts warn

Novavax promises a turnaround & Lilly roils the obesity market

Why are Kaiser Permanente staff considering a strike?

entertainment

AI for drug discovery: Experts on separating hype from reality

Medical student insurance fails on mental health care coverage

Changes to biosimilar regulatory framework must prioritize patients

Changes to biosimilar regulatory framework must prioritize patients

How AI helped researchers track recovery from depression

Most antidepressants don't work on kids, teens, study finds

hotspot

explore

Wikipedia

hotspot